Biblio Discovery — Demo Discovery Service

18 results for "Iris Lin"

Showing 1–18 · 0.20 seconds · RSS

  1. Journal Article

    The impact of non-native accented English on rendition accuracy in simultaneous interpreting

    I-hsin Iris Lin; Feng-lan Ann Chang; Feng-lan Kuo

    Translation and Interpreting : the International Journal of Translation and Interpreting…, Vol. 5 No. 2 · 2013 · English · DOAJ Scopus

    Accent is known to cause comprehension difficulty, but empirical interpreting studies on its specific impact have been sporadic. According to Mazzetti (1999), an accent is composed of deviated phonemics and prosody, both discussed extensively in the TESL discipline. The current study seeks to…

  2. Journal Article

    Patient-Reported and Economic Racial and Ethnic Disparities in Patients with Psoriatic Arthritis: Results from the National Health and Wellness Survey

    Iris Lin; Kathryn Krupsky; Nate Way et al.

    Rheumatology and Therapy, Vol. 11 No. 6 · 2024 · English · DOAJ Scopus

    Abstract Introduction Psoriatic arthritis (PsA) is a chronic, autoimmune form of arthritis that is associated with a substantial humanistic and economic burden. Potential differences in patient-reported outcomes (PROs) and economic outcomes among groups of varying PsA severity and different…

  3. Journal Article

    Intraoral Photography Recommendations for Remote Risk Assessment and Monitoring of Oral Mucosal Lesions

    Iris Lin; Madhurima Datta; Denise M. Laronde et al.

    International Dental Journal, Vol. 71 No. 5 · 2021 · English · DOAJ Scopus

    Oral cancer is a global health issue with substantial morbidity and a high mortality rate mainly because of late-stage diagnosis. Cancerous lesions are often preceded by potentially malignant lesions that may be detected during routine dental examinations. Not only is the oral cavity easily…

  4. Journal Article

    Estimated Cost of Adverse Event Management in Treatment Naïve Non-small Cell Lung Cancer Patients with Common EGFR Mutations Treated with Amivantamab Plus Lazertinib and Osimertinib Plus Chemotherapy

    Alexander Spira; Pratyusha Vadagam; Iris Lin et al.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · English · DOAJ Scopus

    # Background Recent clinical trials have demonstrated improved efficacy of combination regimens, including amivantamab plus lazertinib and osimertinib plus platinum-based chemotherapy, compared with standard therapy in patients with epidermal growth factor receptor (EGFR)–mutated non-small cell…

  5. Journal Article Full text

    Triggers and alleviating factors for fatigue in Parkinson’s disease

    Iris Lin; Briana Edison; Sneha Mantri et al.

    PLOS ONE, Vol. 16 No. 2 · 2021 · English · PLOS Scopus

    Background: Fatigue is common in Parkinson’s Disease, but few effective treatments are available for it. Exploring triggers and alleviating factors, including effects of exercise, could inform development of management strategies for Parkinson’s Disease fatigue. Objectives: To examine triggers and…

    Also available at: DOAJ

  6. Journal Article

    Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study

    Aarti A. Patel; Shannon Allen Ferrante; Iris Lin et al.

    Rheumatology and Therapy, Vol. 10 No. 5 · 2023 · English · DOAJ Scopus

    Abstract Introduction In patients with psoriatic arthritis (PsA), potential differences in care by race/ethnicity have not been well studied. Methods This retrospective, observational cohort analysis utilized the IBM MarketScan® Multi-State Medicaid database. Patients aged ≥ 18 years with two or…

  7. Journal Article

    Real-world treatment patterns of patients with EGFR exon 20 insertion–mutated advanced NSCLC treated with amivantamab or mobocertinib after platinum-based chemotherapy: A multi-database cohort study

    Alexander Spira; Dexter Waters; Tao Ran et al.

    Cancer Treatment and Research Communications, Vol. 44 · 2025 · English · DOAJ Scopus

    Objective: To describe characteristics, treatment patterns, and outcomes of patients with EGFR exon 20 insertion (exon20ins)-positive advanced or metastatic non–small cell lung cancer (NSCLC) who received amivantamab or mobocertinib monotherapy after platinum-based chemotherapy (PBC). Patients and…

  8. Journal Article

    Ventral pallidum neurons projecting to the ventral tegmental area reinforce but do not invigorate reward-seeking behavior

    Dakota Palmer; Christelle A. Cayton; Alexandra Scott et al.

    Cell Reports, Vol. 43 No. 1 · 2024 · English · DOAJ Scopus

    Summary: Reward-predictive cues acquire motivating and reinforcing properties that contribute to the escalation and relapse of drug use in addiction. The ventral pallidum (VP) and ventral tegmental area (VTA) are two key nodes in brain reward circuitry implicated in addiction and cue-driven…

  9. Journal Article

    Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen‐B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

    Philip J. Mease; Soumya D. Chakravarty; Robert R. McLean et al.

    ACR Open Rheumatology, Vol. 4 No. 5 · 2022 · English · DOAJ Scopus

    Objective Axial disease is common and burdensome in patients with psoriatic arthritis (PsA). Human leukocyte antigen‐B27 (HLA‐B27) is a risk factor for axial PsA; treatment response by HLA‐B27 status is inadequately characterized. This study evaluated responses to biologic disease‐modifying…

  10. Journal Article

    Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims data

    David Waterhouse; Iris Lin; Laura Morrison et al.

    BMC Pulmonary Medicine, Vol. 26 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Approximately 17% of patients with non-small cell lung cancer (NSCLC) have epidermal growth factor receptor mutations (EGFRm). Amivantamab received United States Food and Drug Administration approvals in advanced NSCLC for patients with EGFR exon 20 insertions (exon20ins) who…

  11. Journal Article

    Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States

    Jonathan I. Silverberg; Feifei Yang; Evo Alemao et al.

    JEADV Clinical Practice, Vol. 3 No. 4 · 2024 · English · DOAJ Scopus

    Abstract Background The potential association of long‐term oral corticosteroid (OCS) use with adverse events (AEs) in patients with bullous pemphigoid (BP) is not well characterized in a real‐world setting. Objectives To evaluate the effect of OCS use and treatment duration on the incident AEs in…

  12. Journal Article

    Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

    David Waterhouse; Iris Lin; Laura Morrison et al.

    Journal of Health Economics and Outcomes Research, Vol. 12 No. 2 · 2025 · English · DOAJ Scopus

    # Background Approximately 17% of patients with non-small cell lung cancer (NSCLC) have epidermal growth factor receptor-mutated (EGFRm) NSCLC, 84% of which are exon 19 deletions (Ex19del)/exon 21 substitutions (L858R). Unmet needs for patients treated with tyrosine kinase inhibitors (TKIs) for…

  13. Journal Article

    Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors

    Jessica A. Walsh; Iris Lin; Ruizhi Zhao et al.

    Drugs - Real World Outcomes, Vol. 11 No. 3 · 2024 · English · DOAJ Scopus

    Abstract Background Treatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human interleukin-23p19-subunit inhibitor, was approved by the United States (US) Food and Drug Administration for the treatment of…

  14. Journal Article

    Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

    Philip J. Mease; Alexis Ogdie; John Tesser et al.

    Rheumatology and Therapy, Vol. 10 No. 6 · 2023 · English · DOAJ Scopus

    Abstract Introduction The aim of this work is to evaluate treatment persistence and clinical outcomes after 6 months of on-label guselkumab use in patients with rheumatologist-diagnosed active psoriatic arthritis (PsA) enrolled in the CorEvitas PsA/Spondyloarthritis Registry. Methods Participants…

  15. Journal Article

    Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies

    Nana A Mensah; Michael J Fassett; Nehaa Khadka et al.

    JMIR Research Protocols, Vol. 14 · 2025 · English · DOAJ Scopus

    BackgroundHemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to…

  16. Journal Article

    Human vs. Machine Learning Based Detection of Facial Weakness Using Video Analysis

    Chad M. Aldridge; Mark M. McDonald; Mattia Wruble et al.

    Frontiers in Neurology, Vol. 13 · 2022 · English · DOAJ Scopus

    BackgroundCurrent EMS stroke screening tools facilitate early detection and triage, but the tools' accuracy and reliability are limited and highly variable. An automated stroke screening tool could improve stroke outcomes by facilitating more accurate prehospital diagnosis and delivery. We…